Page last updated: 2024-10-18

dihydroxyphenylalanine and Pancreatic Diseases

dihydroxyphenylalanine has been researched along with Pancreatic Diseases in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Pancreatic Diseases: Pathological processes of the PANCREAS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Beek, AP1
de Heide, LJ1
van Ginkel, B1
Slart, RH1
van der Horst-Schrivers, AN1
Boellaard, R1
de Vries, EG1
Noordzij, W1
Glaudemans, AW1
Nilova, TN1
Vashetko, RV1
Khegaĭ, MD1

Other Studies

2 other studies available for dihydroxyphenylalanine and Pancreatic Diseases

ArticleYear
Pancreatic Uptake by 18F-FDOPA PET/CT in Patients With Hypoglycemia After Gastric Bypass Surgery Compared With Controls With or Without Carbidopa Pretreatment.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:3

    Topics: Adult; Aged; Carbidopa; Case-Control Studies; Dihydroxyphenylalanine; Dopamine Agents; Female; Fluor

2017
[Pharmacological analysis of morphofunctional changes in the adrenergic structures of the pancreas as affected by lesions of the endocrine and exocrine pancreas].
    Biulleten' eksperimental'noi biologii i meditsiny, 1988, Volume: 105, Issue:4

    Topics: Adrenergic Fibers; Animals; Atropine; Dihydroxyphenylalanine; Hexamethonium Compounds; Male; Norepin

1988